If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Form 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)

3 Feb 2021 12:14

Form 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCREIGHTONS PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure02 FEBRUARY 2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO We control no voting rights in the Offeree – INNOVADERMA PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORDINARY 1p
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:1,039,0001.6047  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:1,039,0001.6047  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
None   

 (b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
NONE    

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
NONE       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
NONE   

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:03 FEBRUARY 2021
Contact name:MARK ELLIOTT
Telephone number:01253 376539

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
23rd Apr 20263:05 pmRNSConfirmation of name change to Potter & Moore
23rd Apr 20267:01 amRNSChange of Name
23rd Apr 20267:00 amRNSTrading update for the year ended 31 March 2026
27th Mar 20264:35 pmRNSDirector / PDMR Shareholding
12th Mar 20265:42 pmRNSBlock Admission Six Monthly Return
5th Feb 202610:23 amRNSDirector/PDMR Shareholding
29th Jan 20269:31 amRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSInterim results for six months ended 30 Sept 2025
15th Sep 20257:00 amRNSBlock Listing and Total Voting Rights
29th Aug 20257:00 amRNSTotal Voting Rights
28th Aug 20253:22 pmRNSResults of Annual General Meeting
14th Aug 20257:00 amRNSExercise of Options, Director Dealing and TVR
30th Jul 20257:00 amRNSPosting of FY25 Annual Report and Notice of AGM
29th Jul 20251:28 pmRNSHoldings(s) in Company
23rd Jul 20252:11 pmRNSPDMR Dealing
16th Jul 20257:00 amRNSFY25 Audited Results and Notice of AGM
9th Jul 202510:30 amRNSNotice of Final Results and Investor Presentation
22nd May 20253:26 pmRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSPromotion of CFO to the Board of Directors
2nd Apr 20257:00 amRNSNotification of transactions by PDMR
1st Apr 20257:00 amRNSNotification of transactions by PDMR
31st Mar 20258:00 amRNSReadmission - Creightons Plc
31st Mar 20257:00 amRNSAdmission to AIM and first day of dealings
25th Mar 20253:23 pmRNSBoard Appointment
24th Mar 20256:00 pmRNSCreightons
20th Mar 202511:36 amRNSDirector/PDMR Shareholding
12th Mar 202512:43 pmRNSBlock listing Interim Review
3rd Mar 20257:33 amRNSResults of the General Meeting
28th Feb 20257:30 amRNSSchedule One - Creightons plc
6th Feb 20251:20 pmRNSProposed Delisting, Admission to AIM, Notice of GM
29th Jan 202512:59 pmRNSBoard Appointment
7th Jan 202511:46 amRNSHolding(s) in Company
10th Dec 20244:10 pmRNSDirectorate Change
28th Nov 20247:00 amRNSHalf-year Report
13th Nov 20247:00 amRNSUpdate on first half trading performance
28th Oct 20245:01 pmRNSNotification under UKLR 6.4.9(2)
25th Sep 20242:09 pmRNSDirector/PDMR Shareholding
20th Sep 202411:53 amRNSBlock listing Interim Review
18th Sep 20242:02 pmRNSTotal Voting Rights
4th Sep 20245:12 pmRNSDirector/PDMR Shareholding
29th Aug 20244:28 pmRNSResult of AGM
12th Aug 20242:14 pmRNSHolding(s) in Company
29th Jul 20243:45 pmRNSDividend Declaration
29th Jul 20241:52 pmRNSHolding(s) in Company
26th Jul 20242:59 pmRNSHolding(s) in Company
25th Jul 20245:30 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSPreliminary Results, Notice of AGM
8th Jul 20247:00 amRNSUpdate on Asset Impairment and Notice of Results
15th Mar 202410:52 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.